FDA approves first-line therapy for peripheral T-cell lymphoma
(HealthDay)—The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral ...
Nov 20, 2018
0
1